FCAR and colitis: Only CD89-transgenic mice receiving IgA-coated BEVsB/L exhibited severe signs of inflammation highlighted by a significant shortening of the colon, significantly elevated levels of intestinal lipocalin, and significantly increased colitis scores in histology readouts (Fig. 7b–d).